Scientific Research Publishing

Infection Prevention Effectiveness in Dental Clinical Settings: A Systematic Review Relevant to U.S. Dental Practice ()

Infection control refers to the protocols and mechanisms that help to guarantee the safety of both the patient and provider; ...

Merck’s LIPFENDRA® (enlicitide) is the First and Only Once-Daily Oral PCSK9 Inhibitor Approved by the U.S. FDA to Reduce LDL-C in Adults with Hypercholesterolemia

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the U.S. Food and Drug Administration (FDA) has approved LIPFENDRA ® (enlicitide) tablets 20 mg as an adjunct ...